Maia Beridze

Tranexamic acid for hyperacute primary IntraCerebral Haemorrhage (TICH-2): an international randomised, placebo-controlled, phase 3 superiority trial

Nikola Sprigg, Katie Flaherty, Jason P. Appleton et al. · The Lancet · 2018 · 481 citations · Full text

Medicine, Pharmacotherapy, Clinical Pharmacology +16

Antiplatelet therapy with aspirin, clopidogrel, and dipyridamole versus clopidogrel alone or aspirin and dipyridamole in patients with acute cerebral ischaemia (TARDIS): a randomised, open-label, phase 3 superiority trial

Philip M. Bath, Lisa J Woodhouse, Jason P. Appleton et al. · The Lancet · 2017 · 180 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Selected acute phase CSF factors in ischemic stroke: findings and prognostic value

Maia Beridze, Roman Shakarishvilil, N Intskirveli et al. · BMC Neurology · 2011 · 69 citations · Full text

Medicine, Clinical Sciences, Neurology +17

Outcomes in Antiplatelet‐Associated Intracerebral Hemorrhage in the TICH‐2 Randomized Controlled Trial

Zhe Kang Law, Michael Desborough, Ian Roberts et al. · Journal of the American Heart Association · 2021 · 33 citations · Full text

Medicine, Hematology, Pharmacotherapy +17

Tranexamic acid to improve functional status in adults with spontaneous intracerebral haemorrhage: the TICH-2 RCT

Nikola Sprigg, Katie Flaherty, Jason P. Appleton et al. · Health Technology Assessment · 2019 · 28 citations · Full text

Medicine, Pharmacotherapy, Anesthesia +16